FDA Mandates Major Labeling Overhaul for All Opioid Pain Medications
On July 31, 2025, the U.S. Food and Drug Administration (FDA) announced sweeping safety labeling changes for all opioid pain medications. This mandate is aimed at making the risks of long-term opioid use — including misuse, addiction, and overdose — clearer for both healthcare professionals and patients (fda.gov). Why This Matters The decision stems from […]